What is an Immunology Treatment Information Service in India?

A digital platform combining telemedicine, patient education, and specialist referral services for India's 15-20 million food allergy and immunology patients. The ₹850Cr addressable market reflects growing pharmaceutical investment (e.g., Novartis's $2 billion Excellergy acquisition) and patient demand for structured medical guidance that current healthcare infrastructure cannot meet.

How much does it cost to start this service in India?

Estimated ₹25-40 lakhs for MVP: Call center setup (₹8-12L), platform development (₹10-15L), compliance & certifications (₹3-5L), initial marketing (₹4-8L). Add ₹5-10L annually for licensing, data privacy infrastructure, and doctor partnerships.

Is this service profitable in India?

Yes. With 5-10% of 15-20M patients seeking structured guidance (750K-2M TAM), revenue streams include: consultation fees (₹500-1,500/patient), corporate wellness partnerships, pharmaceutical referral commissions, and premium diagnostic packages. At 10% TAM penetration and ₹800 ARPU, annual revenue potential is ₹60-160 Cr by year 3.

What regulations apply to this service in India?

Register under Shop & Establishment Act (state-level); obtain GST registration (5% on Health Services under GST); comply with HIPAA-equivalent privacy standards for patient records; secure written consent from doctors for referral partnerships; adhere to Medical Council regulations (state IMA chapters); implement telemedicine guidelines per Telemedicine Practice Guidelines 2020 (MoHFW).

Immunology Treatment Info Service India 2026 | Patient Guide

AI SummaryIndia's immunology treatment market is fragmented: 15-20 million patients with food allergies and immunology conditions lack access to reliable diagnostic pathways and specialist networks, creating an ₹850Cr addressable market opportunity. Pharmaceutical companies (Novartis, GSK) are aggressively investing in treatment development, but patient awareness and accessibility remain critical gaps. A digital platform combining call centers, specialist matching, and treatment education is well-positioned to capture 5-10% market share by 2026. Founders with healthcare operations, patient acquisition, and regulatory expertise should pursue this in Tier-1 cities first (Mumbai, Delhi, Bangalore) before expanding nationally.